Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review

Pre-exposure prophylaxis (PrEP) medication is a key component of the HIV prevention strategy in the US, which has been demonstrated to be highly effective in preventing HIV acquisition among individuals at risk. Two PrEP medications are currently approved: emtricitabine/tenofovir disoproxil fumarate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fields, Sheldon D., Tung, Elyse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875561/
https://www.ncbi.nlm.nih.gov/pubmed/33569743
http://dx.doi.org/10.1007/s40121-020-00384-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875561/
https://www.ncbi.nlm.nih.gov/pubmed/33569743
http://dx.doi.org/10.1007/s40121-020-00384-5

Ejemplares similares